A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Email
Print
| Listen: | Note: There is multimedia content on this page which requires the Flash viewer. To see it, download and install the Flash plugin here: Macromedia Flash Player |
 |
Researchers are exploring cancer vaccines and new therapies to stimulate the body's immune system to fight cancer. One of the leaders in this research is Scott E. Strome, M.D., professor and chairman of the Department of Otorhinolaryngology (ear, nose and throat) at the University of Maryland School of Medicine and chief of Otorhinolaryngology at the University of Maryland Medical Center. He explains the difference between vaccines to prevent cancer, such as the new vaccine to prevent cervical cancer, and vaccines to treat existing cancers.
In this interview with Karen Warmkessel, Dr. Strome also discusses his research involving a "Trojan peptide" vaccine to treat squamous cell carcinoma, a common type of head and neck cancer.
We would like your feedback about Medically Speaking. If you'd like to contact us, please e-mail media@umm.edu.
Click to Print
Print Preview
Click to Print
Print Preview
